BRIEF-Neurocrine submits NDA for Valbenazine
August 29, 2016 at 16:22 PM EDT
* Submits new drug application for Valbenazine for treatment of tardive dyskinesia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.